Company: SUZ
Filing Date: 2025-04-28
Form Type: 20-F
Source: 0001628280-25-020368
Chunk: 128

Company: Suzano S.A.
Filing Date: 2025-04-28
Form: 20-F
Item: Item 5
Chunk 128
---
 To support all these innovation fronts, we invested R$174.0 million in 2024.

Regarding forestry technology and innovation, our efforts are targeted at eucalyptus breeding, biotechnology, forest management, soil nutrition and forest protection. Our goal is to continue improving our planted forest productivity and quality in a sustainable way. Based on this purpose, our research group is developing new eucalyptus clones based on growth, cellulose content and wood quality, by making use of state-of-the-art techniques like genetic recombination through controlled pollination, to explore all the germplasm’s diversity genomic tools for the selection of new clones, extensive field evaluation and laboratory analysis.

Suzano's genetic selection department has recommended 51 genetic materials for operational planting in 2025, demonstrating improved recommendations compared to 2024 in both the MAI and MAICel indicators (Mean Annual Increment and Mean Annual Increment of Cellulose per hectare per year). Productivity gains were estimated by Tetrys (The Eucalyptus Tree Reliable Yield System), which optimizes Suzano's clonal allocation scenarios. The implementation of a Transition Nursery is a groundbreaking innovation introduced by Suzano in the forestry sector, designed to produce large-scale seedlings of promising clones. In 2024, the Transition Nurseries began operating, resulting in the production of more than 320,000 seedlings and 17 new potential clones. Genetic improvement has also made significant strides with an innovative technique known as Speed Breeding, which is revolutionizing clonal development, reducing the breeding cycle to generate new clones from 21 to just 7 years.

FuturaGene leverages biotechnology to enhance forestry productivity, resilience, and sustainability. With R& D centers in Israel and Brazil, we pioneer innovations in eucalyptus to sustainably intensify its production, which helps reduce fossil fuel consumption, water usage, and chemical inputs - thereby delivering both environmental and economic benefits while promoting safer working conditions.

Using state-of-the-art technologies such as bioinformatics, genomics, gene transformation, and gene editing, we focus on increasing eucalyptus productivity while reducing inputs and carbon footprint across cultivation and industrial processes.

Table of Co ntents

In 2024, FuturaGene received three new commercial approvals from the National Biosafety Technical Commission (CTNBio) for genetically modified (GM) eucalyptus varieties featuring triple-stacked traits: enhanced yield, herbicide tolerance and insect resistance. These approvals were granted after rigorous evaluations and